Search

everythinglearnresearchcommunity

for

Search:↓

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Female pattern hair loss does not significantly affect sexual dysfunction.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.